CN1238196A - Chinese-medicinal capsule (Qianlikang bao capsule) for treating prostatitis - Google Patents

Chinese-medicinal capsule (Qianlikang bao capsule) for treating prostatitis Download PDF

Info

Publication number
CN1238196A
CN1238196A CN 98113990 CN98113990A CN1238196A CN 1238196 A CN1238196 A CN 1238196A CN 98113990 CN98113990 CN 98113990 CN 98113990 A CN98113990 A CN 98113990A CN 1238196 A CN1238196 A CN 1238196A
Authority
CN
China
Prior art keywords
radix
rhizoma
capsule
time
carapax
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN 98113990
Other languages
Chinese (zh)
Inventor
陈春森
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN 98113990 priority Critical patent/CN1238196A/en
Publication of CN1238196A publication Critical patent/CN1238196A/en
Pending legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

A Chinese medicinal capsule for treating prostatitis is prepared from 23 Chinese medicinal materials including coptis root, phellodendron bark, chinaroot, rehmannia root, astragalus root, etc., and features scientific prescription, widely available raw materials, high curative effect and high safety.

Description

The prostatitic Chinese medicine of a kind of treatment-QIANLIEKANG health-care capsule
The present invention relates to the prostatitic Chinese medicine of a kind of treatment (QIANLIEKANG health-care capsule), it is processed through repeatedly engineer testing and science by 23 prescriptions formed of flavor Chinese medicines and develops, prove by the test of pesticide effectiveness, function with clearing away heat-damp and promoting diuresis, promoting blood circulation to remove blood stasis, enriching yin and nourishing kidney, antibiotic pain relieving, be a kind of specially good effect oral medicine in urology department and the Andriatrics Dept. field, the treatment that is specially adapted to acute and chronic prostatitis, prostate hyperplasia, hyposexuality, impotence and premature ejaculation patient is used.
Prostatitis is the higher peculiar pathological changes of male's sickness rate, is that the prostatitis due to a kind of prostate nonspecific infection sexually revises.Western medical treatment is at present still based on anti-inflammation and physiotherapy, owing to lack the wholistic therapy to body, often can not effect a radical cure, the state of an illness is very easy develop into chronic.Motherland's medical science thinks that this disease is similar to " stranguria caused by overstrain ", " pyretic stranguria ", " outstanding pain ", and its diagnosis and treatment are had long history and accumulated abundant clinical experience and more complete theory, and the utmost point is treated further excavation, exploitation, arrangement, raising.We pass through series of experiment research according to its pathogeny for this reason, according to well-known doctor's prescription screening Chinese medicine, and, reached good result of use and practical value in conjunction with the Chinese herbal medicine composition prescription determination of treatment based on pathogenesis obtained through differentiation of symptoms and signs that the modern medicine technology screening goes out to have anti inflammatory detoxication, diuretic damp eliminating and adjusting immunologic function.
Purpose of the present invention is exactly to provide a kind of prostatitic safe and reliable, Chinese medicine that curative effect is high for the treatment of for clinical.
In order to reach the purpose of the high curative effect of the present invention, except that according to experience and the modern medicine technology screening prescription, also pay special attention to the scientific technology process, it is made of by weight following component basically: Rhizoma Coptidis: Cortex Phellodendri: Radix Gentianae: Rhizoma Smilacis Glabrae: the Radix Rehmanniae: the Radix Astragali: Radix Salviae Miltiorrhizae: Radix Achyranthis Bidentatae: Radix Paeoniae Rubra: Rhizoma Chuanxiong: Poria: Rhizoma Alismatis: Cortex Moutan: Caulis Akebiae: Folium Bambusae: Pericarpium Citri Reticulatae: Radix Bupleuri: the Rhizoma Anemarrhenae: Bi : Carapax et Plastrum Testudinis: Cordyceps: Hippocampus: Spora Lygodii=1: 2: 2: 6: 3: 3: 2: 2: 2: 2: 2: 2: 2: 2: 2: 1: 2: 2: 2: 2: 1: 1: 2.
Its preparation method is:
1, gets Hippocampus, Carapax et Plastrum Testudinis, Cordyceps, Spora Lygodii according to the above ratio and be impalpable powder altogether.
2, taking by weighing Rhizoma Coptidis, Cortex Phellodendri, Radix Gentianae, Rhizoma Smilacis Glabrae, the Radix Rehmanniae, the Radix Astragali, Radix Salviae Miltiorrhizae, Radix Achyranthis Bidentatae, Radix Paeoniae Rubra, Rhizoma Chuanxiong, Poria, Rhizoma Alismatis, Cortex Moutan, Caulis Akebiae, Folium Bambusae, Pericarpium Citri Reticulatae, Radix Bupleuri, the Rhizoma Anemarrhenae, Bi  according to the above ratio decocts with water three times, 3 hours for the first time, 2 hours for the second time, 1 hour for the third time, collecting decoction filters, filtrate is concentrated into relative density to be that 1.08 (80 ℃ of surveys) are put cold, add ethanol, make to contain alcohol amount and reach 40-45%, stir evenly and leave standstill, get the clear paste that supernatant concentration to relative density is 1.35 (30 ℃ of surveys).
3, with clear paste and above-mentioned fine powder mixing, drying, pulverizing, cross 100 mesh sieves, " 0 " number capsule of granulating, pack into, promptly.
Advantage of the present invention is:
1, scientific formula: promptly according to the experience prescription of distinguished veteran doctors of TCM again according to modern medicine technology screening Chinese medicine preparation, execute on the basis of controlling to have breakthrough at differential diagnosis in tcm.
2, medicine source abundance, no in great shortage, valuable product, used medical material are neither violated wild animal conservation law and are not destroyed the environmental ecology balance again.
3, technical process is simple, easy to perform is sharp promotes the use of.
4, evident in efficacy, through clinical verification, use the present invention and treat acute prostatitis, cure rate can reach 74.63%, and total effective rate is 95.6%, the treatment chronic prostatitis, cure rate is 61.75%, and total effective rate is 86.1%, in addition prostate hyperplasia, sexual impotence, premature ejaculation and some infertility is also had curative effect preferably, the present invention proves through zoopery, and is without any side effects
Describe the present invention in detail below in conjunction with embodiment:
Embodiment one: the present invention is made up of following component (by weight) basically: Rhizoma Coptidis: Cortex Phellodendri: Radix Gentianae: Rhizoma Smilacis Glabrae: the Radix Rehmanniae: the Radix Astragali: Radix Salviae Miltiorrhizae: Radix Achyranthis Bidentatae: Radix Paeoniae Rubra: Rhizoma Chuanxiong: Poria: Rhizoma Alismatis: Cortex Moutan: Caulis Akebiae: Folium Bambusae: Pericarpium Citri Reticulatae: Radix Bupleuri: the Rhizoma Anemarrhenae: Bi : Carapax et Plastrum Testudinis: Cordyceps: Hippocampus: Spora Lygodii=1: 2: 2: 6: 3: 3: 2: 2: 2: 2: 2: 2: 2: 2: 2: 1: 2: 2: 2: 2: 1: 1: 2;
Its preparation method is:
1, gets Hippocampus 50g, Carapax et Plastrum Testudinis 100g, Cordyceps 50g, Spora Lygodii 100g according to the above ratio and be impalpable powder altogether.
2, all the other take by weighing Rhizoma Coptidis 50g according to the above ratio, Cortex Phellodendri 100g, Radix Gentianae 100g, Rhizoma Smilacis Glabrae 300g, Radix Rehmanniae 150g, Radix Astragali 150g, Radix Salviae Miltiorrhizae 100g, Radix Achyranthis Bidentatae 100g, Radix Paeoniae Rubra 100g, Rhizoma Chuanxiong 100g, Poria 100g, Rhizoma Alismatis 100g, Cortex Moutan 100g, Caulis Akebiae 100g, Folium Bambusae 1 00g, Pericarpium Citri Reticulatae 50g, Radix Bupleuri 100g, Rhizoma Anemarrhenae 100g, Bi  100g decocts with water three times, 3 hours for the first time, 2 hours for the second time, 1 hour for the third time, collecting decoction filters, it is that 1.08 (80 ℃ of surveys) are put cold that filtrate is concentrated into relative density, add ethanol, make to contain alcohol amount and reach 40-45%, stir evenly and leave standstill, getting supernatant concentration to relative density is the clear paste of 1.35 (30 ℃ of surveys).
3, with clear paste and above-mentioned fine powder mixing, drying, pulverizing, cross 100 mesh sieves, " 0 " number capsule of granulating, pack into, promptly.

Claims (1)

1, the prostatitic Chinese medicine of a kind of treatment, it is characterized in that it basically by following component by weight forming: Rhizoma Coptidis: Cortex Phellodendri: Radix Gentianae: Rhizoma Smilacis Glabrae: the Radix Rehmanniae: the Radix Astragali: Radix Salviae Miltiorrhizae: Radix Achyranthis Bidentatae: Radix Paeoniae Rubra: Rhizoma Chuanxiong: Poria: Rhizoma Alismatis: Cortex Moutan: Caulis Akebiae: Folium Bambusae: Pericarpium Citri Reticulatae: Radix Bupleuri: the Rhizoma Anemarrhenae: Bi : Carapax et Plastrum Testudinis: Cordyceps: Hippocampus: Spora Lygodii=1: 2: 2: 6: 3: 3: 2: 2: 2: 2: 2: 2: 2: 2: 2: 1: 2: 2: 2: 2: 1: 1: 2;
The extracting mode of its raw material is:
(1) get according to the above ratio Hippocampus, Carapax et Plastrum Testudinis, Cordyceps, Spora Lygodii, be impalpable powder altogether;
(2) all the other 19 flavor Chinese medicines take by weighing according to the above ratio and decoct with water three times, and 3 hours for the first time, 2 hours for the second time, 1 hour for the third time, collecting decoction, filtration, concentrated were put cold, add ethanol, make to contain the alcohol amount and reach 40-45%, stir evenly, leave standstill, get the clear paste of supernatant concentration;
(3) qinghuo reagent and above-mentioned fine powder mixing, drying, pulverized 100 mesh sieves, granulate, incapsulate, promptly.
CN 98113990 1998-05-15 1998-05-15 Chinese-medicinal capsule (Qianlikang bao capsule) for treating prostatitis Pending CN1238196A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN 98113990 CN1238196A (en) 1998-05-15 1998-05-15 Chinese-medicinal capsule (Qianlikang bao capsule) for treating prostatitis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN 98113990 CN1238196A (en) 1998-05-15 1998-05-15 Chinese-medicinal capsule (Qianlikang bao capsule) for treating prostatitis

Publications (1)

Publication Number Publication Date
CN1238196A true CN1238196A (en) 1999-12-15

Family

ID=5223676

Family Applications (1)

Application Number Title Priority Date Filing Date
CN 98113990 Pending CN1238196A (en) 1998-05-15 1998-05-15 Chinese-medicinal capsule (Qianlikang bao capsule) for treating prostatitis

Country Status (1)

Country Link
CN (1) CN1238196A (en)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1294954C (en) * 2004-03-12 2007-01-17 天津中新药业集团股份有限公司隆顺榕制药厂 Medicine for treating urethra infestation and prostatitis and its preparation method
CN100413520C (en) * 2006-06-13 2008-08-27 胡广德 Medicine for treating prostatitis
CN100457152C (en) * 2006-02-08 2009-02-04 南京蓝本科技有限公司 Chinese medicinal composition for treating chronic prostatitis, its preparation method and purpose
CN101623457B (en) * 2009-07-31 2011-06-29 程立法 Traditional Chinese medicine for treating chronic prostatitis
CN105434684A (en) * 2015-12-31 2016-03-30 河南弘烨生物科技有限公司 Abelmoschus manihot flower containing traditional Chinese medicine preparation for preventing and treating prostate disease and preparation method of traditional Chinese medicine preparation

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1294954C (en) * 2004-03-12 2007-01-17 天津中新药业集团股份有限公司隆顺榕制药厂 Medicine for treating urethra infestation and prostatitis and its preparation method
CN100457152C (en) * 2006-02-08 2009-02-04 南京蓝本科技有限公司 Chinese medicinal composition for treating chronic prostatitis, its preparation method and purpose
CN100413520C (en) * 2006-06-13 2008-08-27 胡广德 Medicine for treating prostatitis
CN101623457B (en) * 2009-07-31 2011-06-29 程立法 Traditional Chinese medicine for treating chronic prostatitis
CN105434684A (en) * 2015-12-31 2016-03-30 河南弘烨生物科技有限公司 Abelmoschus manihot flower containing traditional Chinese medicine preparation for preventing and treating prostate disease and preparation method of traditional Chinese medicine preparation

Similar Documents

Publication Publication Date Title
CN102512590B (en) Chinese medicine for treating reversible pulpitis and preparation method thereof
CN1065134C (en) Quick-acting preparation for litholysis
CN102988905B (en) Traditional Chinese medicine preparation for treating epilepsia and preparation method thereof
CN1178675C (en) Toxin-discharging liver-fortifying medicine
CN1436564A (en) Liver cancer treating medicine and its prepn
CN1181849C (en) Gastropathy treating Chinese medicine
CN101474361A (en) Chinese medicine for treating cerebropathy
CN100490836C (en) Medicine composition for treating osseous arthritis, and its preparation method
CN1238196A (en) Chinese-medicinal capsule (Qianlikang bao capsule) for treating prostatitis
CN101822780A (en) Medicament for treating oral ulcer and preparation method thereof
CN1159037C (en) Medicine for treating apoplexy
CN1233483A (en) Traditional Chinese medicine for treating cirrhosis and liver cancer
CN1077896A (en) Medicine for psoriasis and manufacture method
CN1365822A (en) 'Shugan Lidan' capsule and its preparing process
CN1517115A (en) Chinese patent drug-Fuyan capsdule for treating chronic pelvic inflammation
CN101181516B (en) Chinese medicine prescription orally taken for curing leukaemia
CN105797092B (en) Yiyuan anti-cold mixture
CN1141780A (en) Human-body purifying agent
CN1634194A (en) Genital disease treating Chinese medicine
CN1113804A (en) Antianemic powder and its preparing method
CN1130529A (en) Aizikangfuning-Chinese patent drug for treating AIDS and preparing process thereof
CN1194733C (en) Medicine for treating hyperthyroidism and its prepn
CN1153044A (en) Thyroid gland pill and producing process thereof
CN1068217C (en) Traditional Chinese medicine for treating skin disease and veneral disease
CN101480486A (en) Three-period Chinese medicine for detoxification and technique for preparing the same

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C01 Deemed withdrawal of patent application (patent law 1993)
WD01 Invention patent application deemed withdrawn after publication